The US Food and Drug Administration on Friday approved the first drug treatment for Peyronies disease a condition that results in severe and sometimes painful curvature of the penis officials said The   marks a new use for the drug Xiaflex which is already used to treat Dupuytrens contracture a disease of the hand that impairs a persons ability to straighten their fingers Xiaflex is a bacterial enzyme  collagenase clostridium histolyticum  that is believed to reduce the buildup of collagen the structural protein that makes up scar tissue Peyronies disease is the result of scar tissue forming beneath the skin of the penis and causing it to deform and bend  degrees or more during an erection The condition can cause a painful erection in some men and prevent intercourse according to doctors According to a   from the drugs maker Auxilium Pharmaceuticals Inc of Chesterbrook Pa between  and  men are diagnosed with Peyronies disease each year Todays approval expands the available treatment options for men experiencing Peyronies disease and enables them in consultation with their doctor to choose the most appropriate treatment option said Dr Audrey Gassman deputy director of the FDAs Division of Bone Reproductive and Urological Products Treatment with Xiaflex involves two injections of the drug into the penile scar tissue and a penile modeling procedure that involves manipulation of the penis by a healthcare provider Currently the drug is available only through a restricted program under a risk evaluation and mitigation strategy due to the potential for serious adverse reactions such as penile fracture  the rupture of tissue within the penis  and other injuries The strategy requires that healthcare practitioners and facilities be specially trained and certified to use the drug Other less severe side effects include penile bruising swelling and pain according to the FDA